Over 54.04 cr Covid vaccine doses provided to states, UTs so far: Govt

More than 54.04 crore Covid vaccine doses have been provided to states and UTs so far, and 1,09,83,510 additional doses are in the pipeline, the Union Health Ministry said on Thursday

Topics
Coronavirus Vaccine | Coronavirus | Health Ministry

Press Trust of India  |  New Delhi 

Visitors wait to get their dose of Covid-19 vaccine at an inoculation centre in Bikaner, Sunday, Aug. 8, 2021. (PTI Photo)
Visitors wait to get their dose of Covid-19 vaccine at an inoculation centre in Bikaner (PTI Photo)

More than 54.04 crore Covid vaccine doses have been provided to states and UTs so far, and 1,09,83,510 additional doses are in the pipeline, the Union said on Thursday.

Of this, the total consumption, including the wastage, is 52,00,96,418 doses, according to data available at 8 am.

A total of 2,55,54,533 COVID-19 vaccine doses are still available with states, Union Territories and private hospitals to be administered, the ministry said.

The Union government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.

The new phase of universalisation of COVID-19 vaccination commenced from June 21, 2021.

The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to states and Union Territories for enabling better planning by them, and streamlining the vaccine supply chain, the ministry stated.

As part of the nationwide vaccination drive, the Government of India has been supporting the states and Union Territories by providing them Covid vaccines free of cost.

In the new phase of the universalisation of the Covid vaccination drive, the government will procure and supply (free of cost) 75 per cent of the vaccines being produced by the vaccine manufacturers in the country to states and UTs.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Thu, August 12 2021. 15:37 IST
RECOMMENDED FOR YOU